SeaCrest Wealth Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $468K | Sell |
6,782
-4,456
| -40% | -$308K | 0.05% | 336 |
|
2025
Q1 | $780K | Sell |
11,238
-278
| -2% | -$19.3K | 0.09% | 223 |
|
2024
Q4 | $991K | Sell |
11,516
-5,947
| -34% | -$512K | 0.1% | 185 |
|
2024
Q3 | $2.08M | Sell |
17,463
-73
| -0.4% | -$8.69K | 0.22% | 82 |
|
2024
Q2 | $2.5M | Buy |
17,536
+475
| +3% | +$67.8K | 0.28% | 54 |
|
2024
Q1 | $2.19M | Sell |
17,061
-106
| -0.6% | -$13.6K | 0.27% | 63 |
|
2023
Q4 | $1.82M | Buy |
17,167
+3,083
| +22% | +$327K | 0.22% | 90 |
|
2023
Q3 | $1.28M | Buy |
14,084
+3,032
| +27% | +$276K | 0.17% | 118 |
|
2023
Q2 | $894K | Buy |
11,052
+1,482
| +15% | +$120K | 0.11% | 190 |
|
2023
Q1 | $761K | Buy |
9,570
+2,058
| +27% | +$164K | 0.1% | 221 |
|
2022
Q4 | $508K | Buy |
7,512
+1,544
| +26% | +$104K | 0.07% | 316 |
|
2022
Q3 | $297K | Buy |
5,968
+652
| +12% | +$32.4K | 0.05% | 430 |
|
2022
Q2 | $296K | Sell |
5,316
-30
| -0.6% | -$1.67K | 0.04% | 468 |
|
2022
Q1 | $297K | Buy |
5,346
+940
| +21% | +$52.2K | 0.03% | 508 |
|
2021
Q4 | $247K | Sell |
4,406
-66
| -1% | -$3.7K | 0.03% | 577 |
|
2021
Q3 | $215K | Sell |
4,472
-304
| -6% | -$14.6K | 0.03% | 606 |
|
2021
Q2 | $200K | Buy |
+4,776
| New | +$200K | 0.02% | 650 |
|
2020
Q1 | – | Sell |
-6,996
| Closed | -$202K | – | 561 |
|
2019
Q4 | $202K | Buy |
+6,996
| New | +$202K | 0.03% | 505 |
|
2019
Q2 | – | Sell |
-7,956
| Closed | -$208K | – | 1402 |
|
2019
Q1 | $208K | Buy |
7,956
+230
| +3% | +$6.01K | 0.04% | 450 |
|
2018
Q4 | $178K | Sell |
7,726
-138
| -2% | -$3.18K | 0.04% | 458 |
|
2018
Q3 | $185K | Buy |
7,864
+1,006
| +15% | +$23.7K | 0.03% | 530 |
|
2018
Q2 | $158K | Buy |
6,858
+62
| +0.9% | +$1.43K | 0.03% | 575 |
|
2018
Q1 | $167K | Buy |
6,796
+220
| +3% | +$5.41K | 0.03% | 541 |
|
2017
Q4 | $176K | Buy |
+6,576
| New | +$176K | 0.03% | 541 |
|